Viking Therapeutics's total assets for Q1 2025 were $866.99M, a decrease of -4.55% from the previous quarter. VKTX total liabilities were $20.07M for the fiscal quarter, a -28.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.